157 related articles for article (PubMed ID: 35712903)
1. General practitioner-centred paediatric primary care reduces risk of hospitalisation for mental disorders in children and adolescents with ADHD: findings from a retrospective cohort study.
Mueller A; Sawicki OA; Günther MP; Glushan A; Witte C; Klaaßen-Mielke R; Gerlach FM; Beyer M; Karimova K
Eur J Gen Pract; 2022 Dec; 28(1):150-156. PubMed ID: 35712903
[TBL] [Abstract][Full Text] [Related]
2. Young adults with ADHD: an analysis of their service needs on transfer to adult services.
Taylor N; Fauset A; Harpin V
Arch Dis Child; 2010 Jul; 95(7):513-7. PubMed ID: 20530525
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
McCarthy S; Wilton L; Murray ML; Hodgkins P; Asherson P; Wong IC
BMC Pediatr; 2012 Jun; 12():78. PubMed ID: 22712630
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
5. GPs' experiences with enhanced collaboration between psychiatry and general practice for children with ADHD.
Hassink-Franke LJ; Janssen MM; Oehlen G; van Deurzen PA; Buitelaar JK; Wensing M; Lucassen PL
Eur J Gen Pract; 2016 Sep; 22(3):196-202. PubMed ID: 27261089
[TBL] [Abstract][Full Text] [Related]
6. Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia.
Hong J; Novick D; Treuer T; Montgomery W; Haynes VS; Wu S; Haro JM
BMC Psychiatry; 2014 Oct; 14():304. PubMed ID: 25358916
[TBL] [Abstract][Full Text] [Related]
7. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
8. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
[TBL] [Abstract][Full Text] [Related]
9. Fall-risk-increasing drugs in older patients: the role of guidelines and GP-centred health care in Germany.
Laux G; Kaufmann-Kolle P; Szecsenyi J; Altiner A; Leutgeb R
Age Ageing; 2023 May; 52(5):. PubMed ID: 37247399
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan RS; Wang S; Crystal S; Olfson M
JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
[TBL] [Abstract][Full Text] [Related]
11. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
12. Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder.
Adler LA; Farahbakhshian S; Romero B; Flood E; Doll H
Postgrad Med; 2019 Sep; 131(7):461-472. PubMed ID: 31340712
[No Abstract] [Full Text] [Related]
13. Attention-Deficit/Hyperactivity Disorder in 2- to 5-Year-Olds: A Primary Care Network Experience.
Bannett Y; Feldman HM; Gardner RM; Blaha O; Huffman LC
Acad Pediatr; 2021 Mar; 21(2):280-287. PubMed ID: 32360494
[TBL] [Abstract][Full Text] [Related]
14. Does intensive multimodal treatment for maternal ADHD improve the efficacy of parent training for children with ADHD? A randomized controlled multicenter trial.
Jans T; Jacob C; Warnke A; Zwanzger U; Groß-Lesch S; Matthies S; Borel P; Hennighausen K; Haack-Dees B; Rösler M; Retz W; von Gontard A; Hänig S; Sobanski E; Alm B; Poustka L; Hohmann S; Colla M; Gentschow L; Jaite C; Kappel V; Becker K; Holtmann M; Freitag C; Graf E; Ihorst G; Philipsen A
J Child Psychol Psychiatry; 2015 Dec; 56(12):1298-313. PubMed ID: 26123832
[TBL] [Abstract][Full Text] [Related]
15. Time protective effect of contact with a general practitioner and its association with diabetes-related hospitalisations: a cohort study using the 45 and Up Study data in Australia.
Ha NT; Harris M; Preen D; Moorin R
BMJ Open; 2020 Apr; 10(4):e032790. PubMed ID: 32273312
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.
Wu EQ; Hodgkins P; Ben-Hamadi R; Setyawan J; Xie J; Sikirica V; Du EX; Yan SY; Erder MH
CNS Drugs; 2012 Jul; 26(7):581-600. PubMed ID: 22712698
[TBL] [Abstract][Full Text] [Related]
17. Use of healthcare services before diagnosis of attention-deficit/hyperactivity disorder: a population-based matched case-control study.
Prasad V; Rezel-Potts E; White P; Downs J; Boddy N; Sayal K; Sonuga-Barke E
Arch Dis Child; 2023 Dec; 109(1):46-51. PubMed ID: 37903632
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
[TBL] [Abstract][Full Text] [Related]
19. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
[TBL] [Abstract][Full Text] [Related]
20. What do general practitioners know about ADHD? Attitudes and knowledge among first-contact gatekeepers: systematic narrative review.
Tatlow-Golden M; Prihodova L; Gavin B; Cullen W; McNicholas F
BMC Fam Pract; 2016 Sep; 17(1):129. PubMed ID: 27605006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
